A positive breast biopsy means the tissue sample contained cancerous or precancerous cells. What happens next depends on exactly what type of cells were found, how abnormal they are, and whether they’ve spread beyond where they started. You won’t be rushed into treatment the same day. Instead, you’ll enter a structured process of further testing, specialist consultations, and treatment planning that typically unfolds over several weeks.
What “Positive” Actually Means
Not all positive results are the same. Your pathology report will place the finding into one of several categories, and each one carries a different level of urgency and a different treatment path.
Atypical hyperplasia: This is a precancerous finding, not cancer itself. The cells look abnormal under a microscope but haven’t become cancerous yet. When atypical hyperplasia shows up on a core needle biopsy, surgical excision is typically the next step. The reason: when surgeons remove the full area of tissue, 10% to 30% of cases are “upgraded” to an actual cancer diagnosis because the small biopsy sample didn’t capture the whole picture. For lower-risk patients with no family history or genetic mutations, closer monitoring with more frequent mammograms may be an option instead of surgery.
Carcinoma in situ (stage 0): The cells are cancerous, but they’re still confined to the milk ducts or lobules where they started. They haven’t broken through into surrounding breast tissue. This is sometimes called “pre-invasive” cancer because it hasn’t yet gained the ability to spread.
Invasive carcinoma: The cancer cells have grown beyond the ducts or lobules into surrounding breast tissue. This is what most people think of as breast cancer. Nearly all breast cancers are carcinomas, and most start in glandular tissue. Invasive doesn’t automatically mean advanced. Many invasive cancers are caught early and are highly treatable.
Reading Your Pathology Report
Your pathology report contains several pieces of information that will shape your entire treatment plan. Understanding the basics can help you follow the conversations you’ll have with your doctors in the coming weeks.
Tumor Grade
Grade describes how abnormal the cancer cells look compared to normal breast cells. It’s scored on a scale of 1 to 3. Grade 1 cells look relatively close to normal and tend to grow slowly. Grade 3 cells look very different from normal and typically grow faster. Your doctor uses this to estimate how aggressive the cancer is likely to behave.
Receptor Status
The pathologist tests the cancer cells for three proteins that sit on their surface, because these proteins determine which treatments will work.
- Estrogen receptor (ER): Positive means the cancer cells grow in response to estrogen. This opens the door to hormone-blocking treatments.
- Progesterone receptor (PR): Similar to ER. Cancers positive for both hormone receptors generally respond well to hormone therapy.
- HER2: A protein that promotes cell growth. HER2-positive cancers are more aggressive but can be treated with targeted therapies designed specifically to block that protein.
Cancers that test negative for all three, called triple-negative breast cancer, tend to have fewer targeted treatment options and a more guarded outlook. Knowing your receptor status is one of the most important pieces of information in the entire report because it directly determines which medications your oncologist will recommend.
Stage
Stage is different from grade. While grade describes how the cells look, stage describes how far the cancer has spread. Stage I means the tumor is small and confined to the breast. Stage II and III involve larger tumors or spread to nearby lymph nodes. Stage IV means the cancer has spread to distant organs. Your biopsy alone doesn’t determine the full stage. That requires additional imaging and sometimes further procedures.
Checking Whether Cancer Has Spread
If your biopsy shows invasive cancer, one of the first questions your team will investigate is whether cancer cells have reached the lymph nodes under your arm. This is done through a sentinel node biopsy, which is usually performed during your breast surgery rather than as a separate procedure.
The sentinel node is the first lymph node that fluid drains to from the area of the tumor. During the procedure, a surgeon identifies this node using a tracer dye or radioactive substance, removes it, and sends it to a pathologist. If that node is cancer-free, the remaining lymph nodes are very likely clear too. If it does contain cancer cells, more lymph nodes may need to be removed, sometimes during the same surgery. The number of affected lymph nodes plays a major role in determining your cancer’s stage and what additional treatment you’ll need.
Your Medical Team
After a positive biopsy, you’ll meet with several specialists, often within a week or two. A surgical oncologist will discuss options for removing the cancer. A medical oncologist focuses on systemic treatments like chemotherapy, targeted therapy, or hormone therapy. If radiation is part of your plan, a radiation oncologist will map out how to deliver it precisely to the tumor area. These specialists typically coordinate with each other, and in many cancer centers they review your case together in what’s called a tumor board before presenting you with a unified recommendation.
Surgery: Lumpectomy vs. Mastectomy
For early-stage breast cancer, your surgeon may offer you a choice between lumpectomy (removing the tumor and a margin of surrounding tissue) and mastectomy (removing the entire breast). If you’re given a choice, it’s often because both options lead to similar long-term survival outcomes. The decision comes down to several personal and medical factors.
Lumpectomy preserves most of the breast but almost always requires radiation therapy afterward to reduce the chance of recurrence. Mastectomy removes more tissue but may eliminate the need for radiation in some cases. People who carry BRCA1 or BRCA2 gene mutations sometimes choose mastectomy as a preventive measure, since their genetic risk of developing a new cancer in the remaining tissue is higher. Having dense breast tissue, despite what many people assume, does not change which surgery is recommended.
There is no universally “better” choice. Your surgeon will help you weigh the size and location of the tumor, your genetics, your comfort level, and your preferences for reconstruction.
How Quickly Treatment Begins
The gap between biopsy and the start of treatment varies, but most people are not waiting months. In studies tracking the timeline, the median wait between a core needle biopsy and surgery was about 8 days, though it ranged widely depending on the type of biopsy and the complexity of the case. What matters is that unnecessary delays are avoided. Research has shown that waiting longer than 30 days after a core needle biopsy is associated with worse outcomes in terms of both disease-free and overall survival.
In practice, the weeks between your biopsy result and surgery are not idle. They’re filled with imaging scans to check for spread, consultations with your care team, possible genetic testing, and treatment planning. Some cancers benefit from chemotherapy before surgery to shrink the tumor first, which means your treatment technically starts before any operation happens.
Genomic Testing and Chemotherapy Decisions
For certain hormone receptor-positive, HER2-negative, early-stage cancers, your oncologist may order a genomic test on the tumor tissue. These tests analyze the activity of specific genes within the cancer to predict how likely it is to recur and whether chemotherapy would meaningfully reduce that risk. The results produce a score that helps you and your oncologist decide whether the benefits of chemotherapy outweigh the side effects, or whether hormone therapy alone is sufficient. Not everyone with a positive biopsy needs chemotherapy, and genomic testing has allowed many patients to safely skip it.
What the First Few Weeks Feel Like
The period right after a positive biopsy is often the hardest, partly because of the emotional weight and partly because of the sheer volume of new information. You’ll receive your pathology report, which can be dense and confusing. You’ll schedule consultations with multiple specialists, sometimes at different locations. You may undergo additional imaging like an MRI or CT scan.
It helps to know that this process, while overwhelming, is designed to gather every piece of information needed before anyone recommends a treatment plan. Breast cancer treatment is not one-size-fits-all. The combination of your tumor’s grade, stage, receptor status, and genomic profile creates a picture that is unique to you, and your team uses all of it to recommend the approach most likely to succeed. Bringing someone with you to appointments, writing down questions ahead of time, and asking for printed copies of your pathology report are small steps that can make the process feel more manageable.